Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 N4 PharmaCathay International Holdings Limited (CTI.L)AvivagenAntisense TherapeuticsBayer Aktiengesellschaft
SymbolLON:N4PLON:CTICVE:VIVASX:ANPFRA:BAYN
Price Information
Current PriceGBX 8.30N/AC$0.51N/A€53.34
52 Week RangeN/AN/AN/AN/ABuy
MarketRank™
Overall Score0.50.70.50.41.3
Analysis Score0.00.00.00.03.3
Community Score2.42.62.52.13.0
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.00.00.0
Earnings & Valuation Score0.00.70.00.00.0
Analyst Ratings
Consensus RecommendationN/AN/AN/AN/ABuy
Consensus Price TargetN/AN/AN/AN/A€69.93
% Upside from Price TargetN/AN/AN/AN/A31.11% upside
Trade Information
Market Cap£15.03 million£14.35 millionC$20.83 millionN/AN/A
BetaN/AN/AN/AN/AN/A
Average Volume2,795,457151,589157,326N/AN/A
Sales & Book Value
Annual Revenue£23,524.00£76.68 millionC$1.19 million$538,099.00N/A
Price / Sales638.910.0024.290.00N/A
CashflowGBX 2 per shareN/AC$0.01 per shareN/AN/A
Price / Cash4.150.0966.254.18N/A
Book ValueGBX 2 per shareGBX 7.70 per shareC($0.15) per shareA$0.02 per shareN/A
Price / Book0.040.00-3.520.00N/A
Profitability
Net IncomeN/AN/AN/AN/AN/A
EPSGBX (1)GBX 0.20C($0.11)A($0.01)N/A
Trailing P/E RatioN/A3.75N/A0.000.00
Forward P/E RatioN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/AN/AN/A
Return on Assets (ROA)N/AN/AN/AN/AN/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.62%49.62%2,402.32%3.25%N/A
Current Ratio22.63%1.64%0.39%14.81%N/A
Quick Ratio22.54%1.46%0.26%13.80%N/A
Ownership Information
Institutional Ownership PercentageN/AN/AN/AN/AN/A
Insider Ownership PercentageN/AN/AN/AN/AN/A
Miscellaneous
Employees51,30014895,955
Shares Outstanding181.08 million1.91 billion56.77 million574.06 millionN/A
Next Earnings DateN/AN/A6/1/2021 (Estimated)N/AN/A
OptionableNot OptionableNot OptionableOptionableNot OptionableNot Optionable
SourceHeadline
FOCUS-Bayer, Corteva in two-dog battle over U.S. soy marketFOCUS-Bayer, Corteva in 'two-dog battle' over U.S. soy market
finance.yahoo.com - April 9 at 7:21 AM
Bayer, Corteva in two-dog battle over U.S. soy marketBayer, Corteva in 'two-dog battle' over U.S. soy market
finance.yahoo.com - April 9 at 7:21 AM
Sustainable agriculture is the next way ESG investors can fight climate changeSustainable agriculture is the next way ESG investors can fight climate change
morningstar.com - March 28 at 10:46 PM
Bayer Aktiengesellschaft (FRA:BAYN) Shares Cross Above Two Hundred Day Moving Average of $49.92Bayer Aktiengesellschaft (FRA:BAYN) Shares Cross Above Two Hundred Day Moving Average of $49.92
americanbankingnews.com - March 27 at 2:24 AM
COVID-19 Impact on Cardiovascular Diagnostics Market by Share, Size, Trend, Industry Growth, Leading Player and Forecast up to 2027COVID-19 Impact on Cardiovascular Diagnostics Market by Share, Size, Trend, Industry Growth, Leading Player and Forecast up to 2027
marketwatch.com - March 26 at 9:27 AM
Bayer Aktiengesellschaft (FRA:BAYN) Shares Cross Above 200-Day Moving Average of $49.98Bayer Aktiengesellschaft (FRA:BAYN) Shares Cross Above 200-Day Moving Average of $49.98
americanbankingnews.com - March 19 at 2:22 AM
Bayer Aktie: Hier muss wieder Bewegung rein! - ChartanalyseBayer Aktie: Hier muss wieder Bewegung rein! - Chartanalyse
4investors.de - March 18 at 12:52 PM
Chemical Report Sojabohnen wieder leichter; Wacker Chemie (WCH) und Bayer (BAYN) etwas festerChemical Report Sojabohnen wieder leichter; Wacker Chemie (WCH) und Bayer (BAYN) etwas fester
wallstreet-online.de - March 17 at 3:09 PM
Bayer: Anleger brauchen mehr GeduldBayer: Anleger brauchen mehr Geduld
4investors.de - March 17 at 3:09 PM
WKN:BAY001 ISIN:DE000BAY0017 Symbol:BAYN Gattung:Aktie Branche:ChemieWKN:BAY001 ISIN:DE000BAY0017 Symbol:BAYN Gattung:Aktie Branche:Chemie
finanztreff.de - March 17 at 3:09 PM
Scotts Miracle-Gro Company (The) -- Moodys affirms Scotts Miracle-Gros Ba2 CFR, upgrades senior unsecured rating to Ba3Scotts Miracle-Gro Company (The) -- Moody's affirms Scotts Miracle-Gro's Ba2 CFR, upgrades senior unsecured rating to Ba3
finance.yahoo.com - March 11 at 12:04 PM
FOCUS-Investors seed indoor farms as pandemic disrupts food suppliesFOCUS-Investors seed indoor farms as pandemic disrupts food supplies
finance.yahoo.com - February 18 at 8:43 AM
Bayer reaches $2 bln deal over future Roundup claimsBayer reaches $2 bln deal over future Roundup claims
finance.yahoo.com - February 3 at 12:49 PM
Bayer (BAYRY) Gets a Boost With Product Approvals and DealsBayer (BAYRY) Gets a Boost With Product Approvals and Deals
finance.yahoo.com - January 26 at 12:57 PM
Pharma Stock Roundup: FDA Nod to MRK, AZN, JNJ, GSK Drugs, LLYs New Antibody DealPharma Stock Roundup: FDA Nod to MRK, AZN, JNJ, GSK Drugs, LLY's New Antibody Deal
finance.yahoo.com - January 22 at 10:51 AM
Mercks (MRK) Heart Failure Drug Vericiguat Gets FDA NodMerck's (MRK) Heart Failure Drug Vericiguat Gets FDA Nod
finance.yahoo.com - January 21 at 12:27 PM
Biotech Stock Roundup: Updates From REGN, GILD & VIR, CVAC Teams Up With BAYRYBiotech Stock Roundup: Updates From REGN, GILD & VIR, CVAC Teams Up With BAYRY
finance.yahoo.com - January 13 at 3:09 PM
CureVac Secures Bayer as a Partner for Its Coronavirus VaccineCureVac Secures Bayer as a Partner for Its Coronavirus Vaccine
finance.yahoo.com - January 7 at 2:47 PM
Bayer Considers Selling Smaller Crop-Care AssetsBayer Considers Selling Smaller Crop-Care Assets
finance.yahoo.com - November 25 at 12:25 PM
Animal Drugs Market Expand Their Businesses with New Investments | Bayer, Boehringer Ingelheim, Ceva Santé Animale, Dechra Pharmaceuticals - re:JerusalemAnimal Drugs Market Expand Their Businesses with New Investments | Bayer, Boehringer Ingelheim, Ceva Santé Animale, Dechra Pharmaceuticals - re:Jerusalem
rejerusalem.com - November 10 at 7:59 PM
Seed Enhancement Product Market Massively Future Growth to 2027 | Bayer, Syngenta, BASF, DOW Agrosciences, Dupont - re:JerusalemSeed Enhancement Product Market Massively Future Growth to 2027 | Bayer, Syngenta, BASF, DOW Agrosciences, Dupont - re:Jerusalem
rejerusalem.com - November 10 at 7:59 PM
Pharmacogenomics Market is Growing So Rapidly || Leading Players – Abbott, AstraZeneca, Bayer AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific - re:JerusalemPharmacogenomics Market is Growing So Rapidly || Leading Players – Abbott, AstraZeneca, Bayer AG, F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific - re:Jerusalem
rejerusalem.com - November 10 at 7:59 PM
Bayer Submits Regulatory Applications for Investigational Drug Finerenone in the US and the EU for Patients with Chronic Kidney Disease and Type 2 Diabetes - BioSpaceBayer Submits Regulatory Applications for Investigational Drug Finerenone in the US and the EU for Patients with Chronic Kidney Disease and Type 2 Diabetes - BioSpace
biospace.com - November 10 at 7:59 PM
Bayers Carbon Initiative Pilot Program Met With Overwhelming Interest - 953mnc.comBayer's Carbon Initiative Pilot Program Met With Overwhelming Interest - 953mnc.com
953mnc.com - November 10 at 7:59 PM
Mediator reports substantial progress in Bayer Roundup settlements - St. Louis Business JournalMediator reports 'substantial progress' in Bayer Roundup settlements - St. Louis Business Journal
bizjournals.com - November 10 at 7:59 PM
DateCompanyBrokerageAction
11/5/2020Bayer AktiengesellschaftBerenberg BankSet Price Target
11/4/2020Bayer AktiengesellschaftIndependent ResearchSet Price Target
11/4/2020Bayer AktiengesellschaftKepler Capital MarketsSet Price Target
11/3/2020Bayer AktiengesellschaftNord/LBSet Price Target
11/3/2020Bayer AktiengesellschaftDZ BankReiterated Rating
11/3/2020Bayer AktiengesellschaftJPMorgan Chase & Co.Set Price Target
11/3/2020Bayer AktiengesellschaftThe Goldman Sachs GroupSet Price Target
11/3/2020Bayer AktiengesellschaftUBS GroupSet Price Target
11/3/2020Bayer AktiengesellschaftBarclaysSet Price Target
11/3/2020Bayer AktiengesellschaftSanford C. BernsteinSet Price Target
10/30/2020Bayer AktiengesellschaftCredit Suisse GroupSet Price Target
10/21/2020Bayer AktiengesellschaftMorgan StanleySet Price Target
(Data available from 4/10/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.